Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Apr 26, 2021 · 10-Q · 26 days after period end · 0001104659-21-054692
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$6.66M | -$8.11M | -$5.03M | -$2.30M |
| EPS Diluted | -$0.19 | — | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed Apr 26, 2021 · 26 d after period end
